Activation of 5-lipoxygenase after oxygen-glucose deprivation is partly mediated via NMDA receptor in rat cortical neurons

Journal of Neurochemistry

Volumn 97, Issue 4, 2006, Pages 992-1004

  Ge, Qiu Fu ^a   Wei, Er Qing ^a   Zhang, Wei Ping ^a   Hu, Xin ^a   Huang, Xiao Jia ^a   Zhang, Lei ^a   Song, Ying ^a   Ma, Zhen Qiu ^a   Chen, Zhong ^a   Luo, Jian Hong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

5 lipoxygenase; Caffeic acid; MK 801; MK 886; NMDA; Oxygen glucose deprivation

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CAFFEIC ACID; GLUCOSE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; LEUKOTRIENE; LEUKOTRIENE B4; LIPOXYGENASE INHIBITOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXYGEN; PEPTIDOLEUKOTRIENE;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; BRAIN CELL; BRAIN HYPOXIA; CELL ACTIVATION; CELL DAMAGE; CELL NUCLEUS MEMBRANE; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ICOSANOID METABOLISM; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTRACELLULAR TRANSPORT; ISCHEMIA; METABOLITE; NONHUMAN; OXYGEN GLUCOSE DEPRIVATION; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; RECEPTOR UPREGULATION; STARVATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANIMALS, NEWBORN; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; ENCEPHALITIS; ENZYME ACTIVATION; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; GLUCOSE; GLUTAMIC ACID; HYPOXIA-ISCHEMIA, BRAIN; LEUKOTRIENES; N-METHYLASPARTATE; NEURONS; OXYGEN; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

ANIMALIA;

EID: 33646084363     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03828.x     Document Type: Article

References (55)

1. Acarin L. Gonzalez B. Castellano B. 2002 Decrease of proinflammatory molecules correlates with neuroprotective effect of the fluorinated salicylate triflusal after postnatal excitotoxic damage. Stroke 33 2499 2505.
2. Arai K. Nishiyama N. Matsuki N. Ikegaya Y. 2001 Neuroprotective effects of lipoxygenase inhibitors against ischemic injury in rat hippocampal slice cultures. Brain Res. Bull. 904 167 172.
3. Araki E. Forster C. Dubinsky J. M. Ross M. E. Iadecola C. 2001 Cyclooxygenase-2 inhibitor NS-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity. Stroke 32 2370 2375.
4. Bonventre J. V. Huang Z. Taheri M. R. O. Leary E. Li E. Moskowitz M. A. Sapirstein A. 1997 Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390 622 625.
5. Brock T. G. Anderson J. A. Fries F. P. Peters-Golden M. Sporn P. H. 1999 Decreased leukotriene C4 synthesis accompanies adherence-dependent nuclear import of 5-lipoxygenase in human blood eosinophils. J. Immunol. 162 1669 1676.
6. Brock T. G. McNish R. W. Peters-Golden M. 1995 Translocation and leukotriene synthetic capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages. J. Biol. Chem. 270 21 652 21 658.
7. Brock T. G. McNish R. W. Peters-Golden M. 1998 Capacity for repeatable leukotriene generation after transient stimulation of mast cells and macrophages. Biochem. J. 329 519 525.
8. Brock T. G. Paine R. 3rd and Peters-Golden M. 1994 Localization of 5-lipoxygenase to the nucleus of unstimulated rat basophilic leukemia cells. J. Biol. Chem. 269 22 059 22 066.
9. Burkert E. Szellas D. Radmark O. Steinhilber D. Werz O. 2003 Cell type-dependent activation of 5-lipoxygenase by arachidonic acid. J. Leukoc. Biol. 73 191 200.
10. Chen X. S. Naumann T. A. Kurre U. Jenkins N. A. Copeland N. G. Funk C. D. 1995 cDNA cloning, expression, mutagenesis, intracellular localization, and gene chromosomal assignment of mouse 5-lipoxygenase. J. Biol. Chem. 270 17 993 17 999.
11. Ciccarelli R. D'Alimonte I. Santavenere C. et al. 2004 Cysteinyl-leukotrienes are released from astrocytes and increase astrocyte proliferation and glial fibrillary acidic protein via cys-LT1 receptors and mitogen-activated protein kinase pathway. Eur. J. Neurosci. 20 1514 1524.
12. Ciceri P. Rabuffetti M. Monopoli A. Nicosia S. 2001 Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br. J. Pharmacol. 133 1323 1329.
13. Dirnagl U. Simon R. P. Hallenbeck J. M. 2003 Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 26 248 254.
14. Donzanti B. A. Yamamoto B. K. 1988 An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life Sci. 43 913 922.
15. Farooqui A. A. Litsky M. L. Farooqui T. Horrocks L. A. 1999 Inhibitors of intracellular phospholipase A2 activity: their neurochemical effects and therapeutical importance for neurological disorders. Brain Res. Bull. 49 139 153.
16. Funk C. D. 2001 Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 1871 1875.
17. Galasso J. M. Miller M. J. Cowell R. M. Harrison J. K. Warren J. S. Silverstein F. S. 2000 Acute excitotoxic injury induces expression of monocyte chemoattractant protein-1 and its receptor, CCR2, in neonatal rat brain. Exp. Neurol. 165 295 305.
18. Goldberg M. P. Choi D. W. 1993 Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J. Neurosci. 13 3510 3524.
19. Golubic M. Prayson R. A. Vargo L. Bondar J. Barnett G. H. 2003 Increased expression of 5-lipoxygenase in glioblastoma multiforme. Adv. Exp. Med. Biol. 525 205 208.
20. Goulet J. L. Snouwaert J. N. Latour A. M. Coffman T. M. Koller B. H. 1994 Altered inflammatory responses in leukotriene-deficient mice. Proc. Natl. Acad. Sci. USA 91 12 852 12 856.
21. Haeggstrom J. Z. Kull F. Rudberg P. C. Tholander F. Thunnissen M. M. 2002 Leukotriene A4 hydrolase. Prostaglandins Other Lipid Med. 68-69 495 510.
22. Helgadottir A. Gretarsdottir S. St Clair D. et al. 2005 Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am. J. Hum. Genet. 76 505 509.
23. Helgadottir A. Manolescu A. Thorleifsson G. et al. 2004 The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36 233 239.
24. Hewett S. J. Uliasz T. F. Vidwans A. S. Hewett J. A. 2000 Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. J. Pharmacol. Exp. Ther. 293 417 425.
25. Hirabayashi T. Shimizu T. 2000 Localization and regulation of cytosolic phospholipase A2. Biochim. Biophys. Acta 1488 124 138.
26. Iadecola C. Niwa K. Nogawa S. Zhao X. Nagayama M. Araki E. Morham S. Ross M. E. 2001 Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl. Acad. Sci. USA 98 1294 1299.
27. Ikeda-Matsuo Y. Ikegaya Y. Matsuki N. Uematsu S. Akira S. Sasaki Y. 2005 Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production. J. Neurochem. 94 1546 1558.
28. Jander S. Schroeter M. Stoll G. 2000 Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia. J. Neuroimmunol. 109 181 187.
29. Kitagawa K. Matsumoto M. Hori M. 2004 Cerebral ischemia in 5-lipoxygenase knockout mice. Brain Res. 1004 198 202.
30. Kwon K. J. Jung Y. S. Lee S. H. Moon C. H. Baik E. J. 2005 Arachidonic acid induces neuronal death through lipoxygenase and cytochrome P450 rather than cyclooxygenase. J. Neurosci. Res. 81 73 84.
31. Lam B. K. Austen K. F. 2002 Leukotriene C4 synthase: a pivotal enzyme in cellular biosynthesis of the cysteinyl leukotrienes. Prostaglandins Other Lipid Med. 68-69 511 520.
32. Lazarewicz J. W. Salinska E. Wroblewski J. T. 1992 NMDA receptor-mediated arachidonic acid release in neurons: role in signal transduction and pathological aspects. Adv. Exp. Med. Biol. 318 73 89.
33. Lee J. M. Zipfel G. J. Choi D. W. 1999 The changing landscape of ischaemic brain injury mechanisms. Nature 399 A7 A14.
34. Lepley R. A. Muskardin D. T. Fitzpatrick F. A. 1996 Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase. J. Biol. Chem. 271 6179 6184.
35. Lohmussaar E. Gschwendtner A. Mueller J. C. Org T. Wichmann E. Hamann G. Meitinger T. Dichgans M. 2005 ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 36 731 736.
36. Mattson M. P. Barger S. W. Begley J. G. Mark R. J. 1995 Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Meth Cell Biol. 46 187 216.
37. Meloni B. P. Majda B. T. Knuckey N. W. 2001 Establishment of neuronal in vitro models of ischemia in 96-well microtiter strip-plates that result in acute, progressive and delayed neuronal death. Neuroscience 108 17 26.
38. Nakayama M. Uchimura K. Zhu R. L. Nagayama T. Rose M. Stetler A. Isakson P. C. Chen J. Graham S. H. 1998 Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischem. Proc. Natl Acad. Sci. USA 95 10 954 10 959.
39. Ohtsuki T. Matsumoto M. Hayashi Y. Yamamoto K. Kitagawa K. Ogawa S. Yamamoto S. Kamada T. 1995 Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain. Am. J. Physiol. 268 H1249 H1257.
40. Peters-Golden M. Brock T. G. 2000 Intracellular compartmentalization of leukotriene biosynthesis. Am. J. Respir. Crit. Care Med. 161 S36 S40.
41. Peters-Golden M. McNish R. W. 1993 Redistribution of 5-lipoxygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun. 196 147 153.
42. Radmark O. 2002 Arachidonate 5-lipoxygenase. Prostaglandins Other Lipid Med. 68-69 211 234.
43. Rouzer C. A. Ford-Hutchinson A. W. Morton H. E. Gillard J. W. 1990 MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J. Biol. Chem. 265 1436 1442.
44. Samuelsson B. 2000 The discovery of the leukotrienes. Am. J. Respir. Crit. Care Med. 161 S2 S6.
45. Schuhmann M. U. Mokhtarzadeh M. Stichtenoth D. O. Skardelly M. Klinge P. M. Gutzki F. M. Samii M. Brinker T. 2003 Temporal profiles of cerebrospinal fluid leukotrienes, brain edema and inflammatory response following experimental brain injury. Neurol. Res. 25 481 491.
46. Shimada A. Satoh M. Chiba Y. Saitoh Y. Kawamura N. Keino H. Hosokawa M. Shimizu T. 2005 Highly selective localization of leukotriene C4 synthase in hypothalamic and extrahypothalamic vasopressin systems of mouse brain. Neuroscience 131 683 689.
47. Shimizu T. Wolfe L. S. 1990 Arachidonic acid cascade and signal transduction. J. Neurochem. 55 1 15.
48. Song Y. Wei E. Q. Zhang W. P. Zhang L. Liu J. R. Chen Z. 2004 Minocycline protects PC12 cells from ischemic-like injury and inhibits 5-lipoxygenase activation. Neuroreport 15 2181 2184.
49. Tomimoto H. Shibata M. Ihara M. Akiguchi I. Ohtani R. Budka H. 2002 A comparative study on the expression of cyclooxygenase and 5-lipoxygenase during cerebral ischemia in humans. Acta Neuropathol. 104 601 607.
50. Vartiainen N. Huang C. Y. Salminen A. Goldsteins G. Chan P. H. Koistinaho J. 2001 Piroxicam and NS-398 rescue neurones from hypoxia/reoxygenation damage by a mechanism independent of cyclo-oxygenase inhibition. J. Neurochem. 76 480 489.
51. Wallis R. A. Panizzon K. L. 1993 Protection from hypoxic and N-methyl-D-aspartate injury with azelastine, a leukotriene inhibitor. Eur. J. Pharmacol. 238 165 171.
52. Weller P. F. Bozza P. T. Yu W. Dvorak A. M. 1999 Cytoplasmic lipid bodies in eosinophils: central roles in eicosanoid generation. Int. Arch. Allergy Immunol. 118 450 452.
53. Werz O. Klemm J. Samuelsson B. Radmark O. 2001 Phorbol ester up-regulates capacities for nuclear translocation and phosphorylation of 5-lipoxygenase in Mono Mac 6 cells and human polymorphonuclear leukocytes. Blood 97 2487 2495.
54. Woods J. W. Coffey M. J. Brock T. G. Singer I. I. Peters-Golden M. 1995 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J. Clin. Invest. 95 2035 2046.
55. Woods J. W. Evans J. F. Ethier D. Scott S. Vickers P. J. Hearn L. Heibein J. A. Charleson S. Singer I. I. 1993 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178 1935 1946.